INTEGRA Biosciences Nordic ApS

Private limited companyCVR 43279092TaastrupActive

INTEGRA Biosciences Nordic ApS is a private limited company, based in Taastrup, active in wholesale of other machinery and equipment, founded in 2022. Equity was negative at the end of 2025 (−DKK 3.2m). After a loss in 2024, the company made a profit of DKK 414k in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 7.1m+72.9% vs. 2024
Net profitDKK 414k+124.3% vs. 2024
Equity−DKK 3.2m+11.3% vs. 2024
Employees6latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 73% (2024 → 2025), to DKK 7.1m.
  • Net profit went from a loss of DKK 1.7m to a profit of DKK 414k (2024 → 2025).

Management and owners, last 24 months

  • New in management: Sven Karl Linder (director, 20/02/2026).
  • Stepped down: Thomas Schrofer (director, 20/02/2026).

Registrations, last 24 months

  • 04/08/2025: Moved to Rugvænget 52C, 2630 Taastrup

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 02022202320242025
EquityNet profit
Financial figures for INTEGRA Biosciences Nordic ApS
2022202320242025Change
Revenuenot statednot statednot statednot stated–
Gross profit−2272,9054,1157,117+72.9%
Operating profit (EBIT)−1,000−765−1,341689+151.4%
Profit before tax−1,033−956−1,700414+124.3%
Net profit−1,033−956−1,700414+124.3%
Total assets2,4318,62411,53410,378−10%
Equity−993−1,950−3,649−3,236+11.3%
Liabilities3,42410,57415,18413,614−10.3%
Cash and cash equivalents9782,3852,4712,565+3.8%
Average number of employees14660%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 1mDKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5mDKK 6mDKK 7m2022202320242025
Gross profitMedian, the industry (1,000 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Negative equity

    Equity was −DKK 3.2m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

4 financial years
Annual reports for INTEGRA Biosciences Nordic ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202526/02/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202406/03/2025The companyPDFXBRL
202301/01/2023 – 31/12/202303/04/2024The companyPDFXBRL
202218/05/2022 – 31/12/202226/04/2023The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
012345608/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

1,000 companies in the database

Comparison with the other companies in wholesale of other machinery and equipment based on the latest financial year.

Gross profitDKK 7.1mNo. 453 of 1,000
Better than 55% of the companies in the industry
Equity−DKK 3.2mNo. 981 of 1,000
Better than 2% of the companies in the industry
Number of employees6No. 488 of 1,000
Better than 51% of the companies in the industry

Industry median: gross profit DKK 6m, net profit DKK 772k, equity DKK 4.8m, 6 employees.

DKK 100kDKK 961kDKK 9.2mDKK 88.8mDKK 401.7mHere
Distribution of gross profit for 957 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 8,362of 69,742
Better than 88%
No. 68,794of 69,964
Better than 2%
Same industry and fewer than 20 employees769 companies in the comparison
No. 228of 769
Better than 70%
No. 756of 769
Better than 2%
Companies that are founded within the last five years16,662 companies in the comparison
No. 1,495of 16,614
Better than 91%
No. 16,384of 16,661
Better than 2%
All companies of type ApS66,508 companies in the comparison
No. 9,281of 66,379
Better than 86%
No. 65,327of 66,505
Better than 2%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of other machinery and equipment
Gross profit
  1. INTEGRA Biosciences Nordic ApSDKK 7.1m
  2. HydraSpecma A/SDKK 854.1m
  3. Sanovo Technology A/SDKK 779.2m
Net profit
  1. INTEGRA Biosciences Nordic ApSDKK 414k
  2. HydraSpecma A/SDKK 142.1m
  3. Sanovo Technology A/SDKK 204.2m
Equity
  1. INTEGRA Biosciences Nordic ApS−DKK 3.2m
  2. HydraSpecma A/SDKK 1.2bn
  3. Sanovo Technology A/SDKK 592.3m
Employees
  1. INTEGRA Biosciences Nordic ApS6
  2. HydraSpecma A/S365
  3. Sanovo Technology A/S216

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • INTEGRA Biosciences Holding AG100%
INTEGRA Biosciences Nordic ApS

Management

3 active registrations

Executive management

Executive management at INTEGRA Biosciences Nordic ApS
NameRoleAppointed
Kirsten ThuesenDirector18/05/2022
Torbjørn GrippDirector18/05/2022
Sven Karl LinderDirector20/02/2026
Founders
INTEGRA Biosciences Holding AG
Former management (1)
Former management at INTEGRA Biosciences Nordic ApS
NameRoleAppointedResigned
Thomas SchroferDirector18/05/202220/02/2026

Signing rule: Selskabet tegnes af to direktører.

Address and production units

1 active production units

Rugvænget 52C
2630 Taastrup

Høje-Taastrup Municipality · Postcode 2630

Production units
Production unitAddressEmployeesP number
INTEGRA Biosciences Nordic ApSRugvænget 52C, 2630 Taastrup61028273793

Purpose

Selskabets formål er at handle med varer, sælge services og dermed forbundet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

13 registered events
20263 changesaccounts 1 · management 2
  • Annual report for 2025 published
  • Sven Karl Linder appointed director
  • Thomas Schrofer stepped down as director
20252 changesaddress 1 · accounts 1
  • Moved to Rugvænget 52C, 2630 Taastrup
  • Annual report for 2024 published
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20226 changesaddress 1 · founded 1 · management 3 · ownership 1
  • Moved to Vallensbækvej 22A, 3. tv, 2605 Brøndby
  • Registered as INTEGRA Biosciences Nordic ApS
  • Thomas Schrofer appointed director
  • Kirsten Thuesen appointed director
  • Torbjørn Gripp appointed director
  • INTEGRA Biosciences Holding AG registered as owner (100%)

Related companies

Same industry in Høje-Taastrup

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction